Chargement en cours...
Protein deimmunization via structure-based design enables efficient epitope deletion at high mutational loads
Anti-drug immune responses are a unique risk factor for biotherapeutics, and undesired immunogenicity can alter pharmacokinetics, compromise drug efficacy, and in some cases even threaten patient safety. To fully capitalize on the promise of biotherapeutics, more efficient and generally applicable p...
Enregistré dans:
| Publié dans: | Biotechnol Bioeng |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2015
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4452428/ https://ncbi.nlm.nih.gov/pubmed/25655032 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/bit.25554 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|